Delivery Order SPE2DB20D1100-SPE2DB25FC1J7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,318.51 on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (30 single-use vials). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a small-value transaction issued under a larger indefinite delivery contract vehicle. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to...
- The Defense Logistics Agency awarded a $6,297.40 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (60-unit package). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a $12,777.96 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will be completed by July 29, 2025, with work performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,293.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units, with a contract ceiling value of $22,836.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,110.43 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive procurement under AmerisourceBergen's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,349.15 to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $18,550.26 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,098.45 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-unit quantities. The contract employs firm fixed price terms and is not set-aside, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract executed under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC1J7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,541.08 for Restasis 0.05% Eye Emulsion (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive procurement under a larger indefinite delivery contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen provides a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and other government agencies. The Restasis procurement fulfills ongoing pharmaceutical supply requirements for Defense Health Agency and other federal healthcare customers through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/6/25 |